This Article Full Text Full Text (PDF) All Versions of this Article: 25/2/442    most recent 01.ATV.0000148404.24271.fcv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hishikawa, K. Articles by Fujita, T. Search for Related Content PubMed PubMed Citation Articles by Hishikawa, K. Articles by Fujita, T.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:442.)
© 2005 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Oral Flavonoid Supplementation Attenuates Atherosclerosis Development in Apolipoprotein E–Deficient Mice

Keiichi Hishikawa; Toshio Nakaki; Toshiro Fujita

From the Departments of Clinical Renal Regeneration and Internal Medicine (K.H., T.F.), Division of Nephrology and Endocrinology, University of Tokyo, Japan; and the Department of Pharmacology (T.N.), Teikyo University School of Medicine, Japan.

Correspondence to Keiichi Hishikawa, Department of Internal Medicine, Division of Nephrology and Endocrinology, University of Tokyo, Hongo, 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan. E-mail hishikawa-tky{at}umin.ac.jp

Objective— Caffeic acid phenethyl ester (CAPE), a natural flavonoid, specifically blocks activation of nuclear factor-B (NF-B). We examined the effects of oral CAPE supplementation on atherogenesis in apolipoprotein E–deficient (apoE–/–) mice.

Methods and Results— Ten-week-old male apoE–/– mice were supplemented orally with CAPE (30 mg/kg body weight) for 12 weeks. At the end of administration, atherosclerosis progression, NF-B activity, gene expression profiling by microarray analysis, and oxidative stress were studied. Treatment of apoE–/– mice with CAPE significantly reduced aortic atherosclerosis, NF-B activity, and expression of NF-B–related genes in the aorta. Moreover, expression of other gene clusters such as basic transcription factors, growth factors, cytokines, cell adhesion proteins, and extracellular matrix were also significantly reduced by treatment with CAPE. Plasma isoprostane level in apoE–/– mice was also significantly reduced by CAPE.

Conclusion— In apoE–/– mice, oral CAPE supplementation attenuates the atherosclerotic process. This may be attributable to direct inhibition of NF-B in the lesion and reduction of systemic oxidative stress.

In apoE–/– mice, oral caffeic acid phenethyl ester (CAPE) supplementation attenuates the atherosclerotic process and reduces NF-B activity and expression of NF-B–related genes in the aorta. This may be attributable to direct inhibition of NF-B in the lesion and reduction of systemic oxidative stress.

Key Words: atherosclerosis • NF-B • microarray • oxidative stress • flavonoid

This article has been cited by other articles:

				B. You, Y.-Y. Jiang, S. Chen, G. Yan, and J. Sun The Orphan Nuclear Receptor Nur77 Suppresses Endothelial Cell Activation Through Induction of I{kappa}B{alpha} Expression Circ. Res., March 27, 2009; 104(6): 742 - 749. [Abstract] [Full Text] [PDF]

				T. A. Barringer, L. Hatcher, and H. C. Sasser Potential Benefits on Impairment of Endothelial Function after a High-fat Meal of 4 weeks of Flavonoid Supplementation Evid. Based Complement. Altern. Med., July 3, 2008; (2008) nen048v1. [Abstract] [Full Text] [PDF]